News & Analysis on Clinical Trial Services & Contract Research And Development
By Melissa Fassbender
- Last updated on
Julian Coe has worked at companies such as LGC Genomics and Ieso Digital Health and told us his ambition of the next six months is to have Repositive become the world’s single largest source of translational cancer models for researchers “to drive the future of precision medicine.”
“My priority is making this ambition a reality through securing funding and helping the team to scale up,” he said.
“I’ve joined at an exciting time, when Repositive is already making waves in the research world and now has a strong team in place.”